Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis?
Quality improvement and practice-based research in neurology using the electronic medical record.
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
Serum lactate as a novel potential biomarker in multiple sclerosis.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
Cognition and eye movements: assessment of cerebral dysfunction.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
The Gut Microbiome and the Brain.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Defining the new end point for multiple sclerosis treatment.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
C-11Utility of the Ten Item Personality Inventory (TIPI) in Multiple Sclerosis (MS): What Can 10 Items Tell Us?
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Ciliary Neurotrophic Factor Role in Myelin Oligodendrocyte Glycoprotein Expression in Cuprizone-Induced Multiple Sclerosis Mice.
Evoked potentials in multiple sclerosis.
Pages
« first
‹ previous
…
277
278
279
280
281
282
283
284
285
…
next ›
last »